The need for independent clinical research companies arrived with the increased need for researchers to conduct clinical studies to obtain approval from the Food and Drug Administration (FDA). New treatment options and changes in recommended treatment regimens are based on the analysis of data collected in clinical trials. Each new drug reaching the market requires an investment of approximately fifteen (15) years and over $100,000,000. After a compound has been “discovered”, pharmaceutical companies conduct extensive pre-clinical safety trials on animal and human cells. If successful, the next step is to conduct similar studies in humans. Studies proceed through a series of “Phases”, each of which must be successfully and safely managed before initiating the next phase. Prior to FDA approval, thousands of human volunteers are consented and should be willing to participate in these experimental phases of study. In the area of Clinical trials, the efficient collection and analysis of remote patient data with minimum cost and maximum security is of utmost importance. The current data-collection methods are outdated and inefficient. Some newer methodologies being adopted by Electronic Data Capture (EDC) vendors assume that login names and passwords will do just fine in protecting business-critical clinical trial data. Alternatively, they go about using a VPN or other expensive networking solutions. The extensive data management expertise of The Clinical Research Group can ensure timeliness, completeness, accuracy and consistency of the data so that it meets the standards of quality expected for reporting to regulatory bodies.